NEW MJ NEWS

MariMed Appoints Jon Levine as Interim Chief Executive Officer

MariMed, Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its Board of Directors (the “Board”) appointed Jon Levine, MariMed’s President, as Interim Chief Executive Officer.

“With a heavy heart on the news of Robert Fireman’s passing, appointing Jon Levine as Interim Chief Executive Officer was an easy decision,” said Edward Gildea, one of MariMed’s independent directors. “As President, Jon has managed the day-to-day facets of MariMed’s operations, and as co-founder of MariMed, has the experience and knowledge of the Company’s innerworkings and growth strategy that are crucial at this juncture.”

The Board will conduct a process to identify a permanent Chief Executive Officer for MariMed, which may include external and internal candidates. The Company will announce an update on the process upon completion. No timing was provided for the duration of the process.

ABOUT MARIMED

MariMed Inc., a multi-state cannabis operator, is dedicated to improving lives every day through its high-quality products, its actions, and its values. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units. Proprietary formulations created by the Company’s technicians are embedded in its top-selling and award-winning products and brands, including Betty’s Eddies, Nature’s Heritage, Bubby’s Baked, K Fusion, Kalm Fusion, and Vibations: High + Energy. For additional information, visit www.marimedinc.com.

For More Information, Contact:

Investor Relations:
Steve West, Vice President, Investor Relations
Email: ir@marimedinc.com
Phone: (781) 277-0007

Media Contact:
Howard Schacter, Chief Communications Officer
Email: info@marimedinc.com
Phone: (781) 277-0007


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Future Farm Technologies Inc. (FFT) SUBSIDIARY COMPLETES SECOND CANNABIS OIL SALE IN CALIFORNIA

  FUTURE FARM SUBSIDIARY COMPLETES SECOND CANNABIS OIL SALE IN CALIFORNIA Future Farm…

$NVLX Submits Application in Australia To Get Orphan Drug Designation For Pancreatic Cancer Treatment

Nuvilex Applies in Australia for the Orphan Drug Designation for Pancreatic Cancer…

Grow Capital, Inc (GRWC) Two Senior Executives Guiding the Company’s Newest Division

Grow Capital Inc (GRWC) Two Senior Executives Guiding the Company’s Newest Division,…

GT Biopharma Inc. (GTBP) Begins Manufacturing of “Non-Opioid” Pain-Brake Drug

GT Biopharma Begins Manufacturing of “Non-Opioid” Pain-Brake Drug to Compete in Multi-Billion…